These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 29365133)
1. Periprocedural myocardial infarction and injury in elective coronary stenting. Zeitouni M; Silvain J; Guedeney P; Kerneis M; Yan Y; Overtchouk P; Barthelemy O; Hauguel-Moreau M; Choussat R; Helft G; Le Feuvre C; Collet JP; Montalescot G; Eur Heart J; 2018 Apr; 39(13):1100-1109. PubMed ID: 29365133 [TBL] [Abstract][Full Text] [Related]
2. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions. Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425 [TBL] [Abstract][Full Text] [Related]
3. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention. Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492 [TBL] [Abstract][Full Text] [Related]
4. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058 [TBL] [Abstract][Full Text] [Related]
5. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes. Yang X; Tamez H; Lai C; Ho K; Cutlip D Catheter Cardiovasc Interv; 2017 Apr; 89(5):849-856. PubMed ID: 27535209 [TBL] [Abstract][Full Text] [Related]
6. Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention. Piccolo R; Leone A; Simonetti F; Avvedimento M; Angellotti D; Manzi L; Verde N; Spaccarotella CAM; Di Serafino L; Cirillo P; Gargiulo G; Fortunato G; Franzone A; Esposito G Catheter Cardiovasc Interv; 2023 Aug; 102(2):212-220. PubMed ID: 37337462 [TBL] [Abstract][Full Text] [Related]
7. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study. Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513 [TBL] [Abstract][Full Text] [Related]
8. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial. Huang Z; Zhuang X; Zhang S; Huang Y; Yuan L; Lin A; Tang L; Xiong Z; Christopher O; Chen Y; Wu B; Ling Y; Li S; Jie Q; Xiong L; Qian X; Liao X; Liu J BMJ Open; 2023 Jul; 13(7):e072541. PubMed ID: 37433737 [TBL] [Abstract][Full Text] [Related]
9. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI). Bulluck H; Paradies V; Barbato E; Baumbach A; Bøtker HE; Capodanno D; De Caterina R; Cavallini C; Davidson SM; Feldman DN; Ferdinandy P; Gili S; Gyöngyösi M; Kunadian V; Ooi SY; Madonna R; Marber M; Mehran R; Ndrepepa G; Perrino C; Schüpke S; Silvain J; Sluijter JPG; Tarantini G; Toth GG; Van Laake LW; von Birgelen C; Zeitouni M; Jaffe AS; Thygesen K; Hausenloy DJ Eur Heart J; 2021 Jul; 42(27):2630-2642. PubMed ID: 34059914 [TBL] [Abstract][Full Text] [Related]
10. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). Stone GW; Maehara A; Muller JE; Rizik DG; Shunk KA; Ben-Yehuda O; Genereux P; Dressler O; Parvataneni R; Madden S; Shah P; Brilakis ES; Kini AS; JACC Cardiovasc Interv; 2015 Jun; 8(7):927-36. PubMed ID: 26003018 [TBL] [Abstract][Full Text] [Related]
11. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study. Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795 [TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial. Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610 [TBL] [Abstract][Full Text] [Related]
13. Association of chronic kidney disease with periprocedural myocardial injury after elective stent implantation: A single center prospective cohort study. Jerkic H; Letilovic T; Stipinovic M; Pocanic D; Catic J; Knotek M Medicine (Baltimore); 2016 Nov; 95(45):e5381. PubMed ID: 27828870 [TBL] [Abstract][Full Text] [Related]
14. Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention. Zhou Y; Chen Z; Chen A; Ma J; Dai C; Lu D; Wu Y; Li S; Chen J; Liu M; Li C; Lu H; Qian J; Ge J Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):871-880. PubMed ID: 34962992 [TBL] [Abstract][Full Text] [Related]
15. Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI. Ueki Y; Otsuka T; Bär S; Koskinas KC; Heg D; Häner J; Siontis GCM; Praz F; Hunziker L; Lanz J; Stortecky S; Pilgrim T; Losdat S; Windecker S; Räber L J Am Coll Cardiol; 2022 Feb; 79(6):513-526. PubMed ID: 35144742 [TBL] [Abstract][Full Text] [Related]
16. Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography. Porto I; Di Vito L; Burzotta F; Niccoli G; Trani C; Leone AM; Biasucci LM; Vergallo R; Limbruno U; Crea F Circ Cardiovasc Interv; 2012 Feb; 5(1):89-96, S1-6. PubMed ID: 22298799 [TBL] [Abstract][Full Text] [Related]
17. Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI. Piccolo R; Leone A; Avvedimento M; Simonetti F; Ippolito D; Angellotti D; Verde N; Manzi L; Cirillo P; Serafino LD; Fortunato G; Franzone A; Esposito G Eur Heart J Qual Care Clin Outcomes; 2023 Nov; 9(7):680-690. PubMed ID: 36385164 [TBL] [Abstract][Full Text] [Related]
18. Acute ischemic events are frequent after primary coronary stenting. Kranjec I; Dzananovic DZ J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):178-88. PubMed ID: 24978874 [TBL] [Abstract][Full Text] [Related]
19. Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention? Tomaniak M; Kołtowski Ł; Kochman J; Huczek Z; Rdzanek A; Pietrasik A; Gasecka A; Gajda S; Opolski G; Filipiak KJ Pol Arch Intern Med; 2017 Nov; 127(11):730-740. PubMed ID: 28817535 [TBL] [Abstract][Full Text] [Related]
20. Impact of albuminuria on the incidence of periprocedural myocardial injury in patients undergoing elective coronary stent implantation. Osugi N; Suzuki S; Ishii H; Yasuda Y; Shibata Y; Tatami Y; Ota T; Kawamura Y; Okumura S; Tanaka A; Inoue Y; Matsuo S; Murohara T Am J Cardiol; 2014 Jul; 114(1):42-6. PubMed ID: 24802297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]